SCHEMBL4644784

SCHEMBL4644784

CCc1cccc2scc(CO)c12

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.52
ALDH1A1 P00352 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
GABRA1 P14867 2/20 0.41
GABRB2 P47870 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.38
CA2 P00918 2/20 0.37
TP53 P04637 2/20 0.36
RXFP1 Q9HBX9 1/20 0.35
CTSG P08311 2/20 0.34
CMA1 P23946 2/20 0.34
MAPT P10636 1/20 0.34
CA1 P00915 1/20 0.34
IDO1 P14902 1/20 0.33
PDCD1 Q15116 1/20 0.33
CD274 Q9NZQ7 1/20 0.33
SLC9A1 P19634 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2314303 0.80 CYP2A6 (0.53) CYP2A6ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL2093290 0.78 CA2 (0.35) CYP2A6ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL15729955 0.76 CYP2A6 (0.53) CYP2A6ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL13888151 0.74 CTSG (0.47) CYP2A6ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL6002815 0.73 ALDH1A1 (0.39) CYP2A6ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL6003593 0.73 ALDH1A1 (0.39) CYP2A6ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL31732993 0.71 GABRA1 (0.48) ALDH1A1CYP2C19GABRA1GABRB2PDCD1
SCHEMBL91157 0.71 CYP2A6 (0.67) CYP2A6ALDH1A1SMN1; SMN2CA2TP53
SCHEMBL954995 0.71 GABRA1 (0.48) ALDH1A1CYP2C19GABRA1GABRB2PDCD1
SCHEMBL508145 0.70 GPR3 (0.54) ALDH1A1CYP1A2CYP2C19GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1298130-B1 3-HYDROXYMETHYLBENZO B THIOPHENE DERIVATIVES AND PROCESS FOR THEIR PREPARATION TEIJIN PHARMA LTD (JP) 2008-08-13 EP disclosed
US-6884896-B2 Benzo[b]thiophene derivatives and process for preparing the same TEIJIN LIMITED (JP) 2005-04-26 US disclosed
US-6774245-B2 SELECTIVE HYDROGENATION OF 7-SUBSTITUTED-3-HYDROXYMETHYL-BENZO(B)THIOPHENE DERIVATIVE; CYCLIZATION, SULFIDING TEIJIN LIMITED (JP) 2004-08-10 US disclosed
US-20030191325-A1 3-Hydroxymethylbenzo[b]thiophene derivatives and process for their preparation TEIJIN LIMITED (JP) 2003-10-09 US disclosed
EP-1298130-A1 3-HYDROXYMETHYLBENZO B THIOPHENE DERIVATIVES AND PROCESS FOR THEIR PREPARATION TEIJIN LIMITED (JP) 2003-04-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030191325-A1 3-Hydroxymethylbenzo[b]thiophene derivatives and process for their preparation TST, SULT1E1, CYP4B1 CYP2A6 163/4885ALDH1A1 473/4885CYP1A2 97/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.